Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial
- Lancet, Apr 04 2024, S0140-6736(24)00413-6 | https://doi.org/10.1016/S0140-6736(24)00413-6